Vaccinia Capping System
NEBU recombinant 37 SAM

GMP-grade reagent also available. Learn more.

Looking for higher capping efficiency and a broader temperature range? Try out new Faustovirus Capping Enzyme.

A full system for enzymatic capping based on the Vaccinia virus Capping Enzyme (VCE)

  • Adds 7-methylguanylate cap structures (Cap-0) to the 5′ end of RNA generated by in vitro transcription
  • Cap-0 is required for efficient translation of the RNA in eukaryotic systems
  • mRNA Cap 2´-O-Methyltransferase (NEB #M0366) is required to generate Cap-1 structure that reduces cellular innate immune response when the RNA is used in vivo.
  • Isolated from a recombinant source
  • Tested for the absence of endonucleases, exonucleases, RNases
Catalog # Concentration Size List Price Your Price Quantity
M2080S 10,000 units/ml 400 units $147.00
Please enter a quantity for at least one size

Need a custom/large volume order? Contact us

Bulk packaging may also be available and requested for large recurring orders.
Learn More

  • Product Information

    Based on the Vaccinia virus Capping Enzyme (VCE), the Vaccinia Capping System provides the necessary components to add 7-methylguanylate cap structures (Cap-0) to the 5´end of RNA (1). In eukaryotes, these terminal cap structures are involved in stabilization (2), transport (3), and translation (4) of mRNAs. Enzymatic production of capped RNA is an easy way to improve the stability and translational competence of RNA used for in vitro translation, transfection, and microinjection. Alternatively, use of labeled GTP in a reaction provides a convenient way to label any RNA containing a 5´ terminal triphosphate.

    Vaccinia capping enzyme is composed of two subunits (D1 and D12). The D1 subunit carries three enzymatic activities (RNA triphosphatase, guanylyltransferase and guanine methyltransferase); all necessary for addition of a complete Cap-0 structure, m7Gppp5'N to 5' triphosphate RNA (5,6). In vitro transcripts can be capped in less than one hour in the presence of the capping enzyme, reaction buffer, GTP, and the methyl donor, SAM. Capping is nearly 100% efficient and all capped structures are added in the proper orientation, unlike co-transcriptional addition of some cap analogs (7).

    Figure 1. 5´ Cap Structure

    Schematic representation of mRNA 5´ cap structure indicating the 7-methylguanosine, shown in yellow, and the 5´ end of the mRNA, shown in blue. The 2´-O-methyl group present in Cap-1 and Cap-2 structures is shown in red.

    Product Source

    An E. coli strain that carries the genes for the Vaccinia (WR) capping enzyme.
    This product is related to the following categories:
    RNA Modification Products,
    RNA Synthesis Products
    This product can be used in the following applications:
    RNA Modification,
    In vitro Transcription for RNA Synthesis
    • Reagents Supplied
    • Properties & Usage
    • Advantages and Features
    • Related Products
    • Product Notes
    • References
  • Protocols, Manuals & Usage
  • FAQs & Troubleshooting
    • FAQs
    • Tech Tips
  • Citations & Technical Literature
    • Citations
    • Publications
  • Quality, Safety & Legal
Loading Spinner